Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03535688 · ClinicalTrials.gov registry record · Phase 2
D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain
A Phase 2 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 203
- Enrollment target
NCT03535688 is a Phase 2 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 203 participants.
The verdict
NCT03535688, a Phase 2 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 203 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of D-cycloserine versus placebo in relieving the signs and symptoms of patients with chronic lower back pain.
Interventions
- DRUG Placebo
- DRUG D-cycloserine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2018-03-30 |
| Est. Completion | 2024-02-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03535688
The ClinicalTrials.gov registry entry for NCT03535688 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03535688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03535688 about?
NCT03535688 is a clinical study titled "D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain". The purpose of this study is to evaluate the efficacy and safety of D-cycloserine versus placebo in relieving the signs and symptoms of patients with chronic lower back pain.
What is the current status of trial NCT03535688?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 203 participants. The study started on 2018-03-30. Estimated completion is 2024-02-07.
What interventions are being tested in trial NCT03535688?
The interventions under investigation include: Placebo (DRUG), D-cycloserine (DRUG).
Who is sponsoring clinical trial NCT03535688?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.